5-Amino-1MQ vs Glutathione (GSH)
Both 5-Amino-1MQ and Glutathione (GSH) are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.
5-Amino-1MQ
Evidence C+5-Amino-1-Methylquinolinium
A small-molecule NNMT inhibitor that has produced fat loss and improved muscle stem-cell function in obese rodents. No human RCTs yet.
View full 5-Amino-1MQ profile →Glutathione (GSH)
Evidence BReduced L-Glutathione
Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.
View full Glutathione (GSH) profile →Side-by-Side
| Attribute | 5-Amino-1MQ | Glutathione (GSH) |
|---|---|---|
| Evidence Grade | C+ | B |
| FDA Status | Not FDA-approved — small-molecule research compound (NNMT inhibitor) | Not FDA-approved as therapeutic — sold as supplement; intravenous use compounded |
| Typical Dose | 50–150 mg orally daily (research-only) | 200–600 mg sublingual / 600–2400 mg IV (compounded) |
| Clinics Indexed | 31 | 312 |
| Categories | fat-loss, longevity | antioxidant, longevity |
Key reported benefits — 5-Amino-1MQ
- ✓NNMT inhibition
- ✓Fat-mass reduction (preclinical)
- ✓Muscle stem-cell support
Key reported benefits — Glutathione (GSH)
- ✓Master antioxidant
- ✓Liver detoxification support
- ✓Oxidative stress reduction
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.